Study suggests a single dose of JYNNEOS vaccine may lessen the severity of mpox illness CDCgov mpox illness infection vaccine vaccination
By Neha MathurJan 3 2023Reviewed by Danielle Ellis, B.Sc. In a recent Morbidity and Mortality Weekly Report posted on the United States of America Center for Disease Control and Prevention website, researchers identified mpox patients who contracted the disease at or after 14 days of receiving one dose of the JYNNEOS vaccine. They compared their demographic and clinical characteristics with unvaccinated people who contracted mpox.
The team considered those who had received a single dose of the JYNNEOS vaccine ≥14 days before contracting mpox disease as vaccinated; and those who had not received the vaccine during the 2022 outbreak or who fell ill before their first vaccination as unvaccinated. The team collected data from the USA immunization registries to analyze the demographic characteristics of the vaccinated vs. unvaccinated persons with mpox.
Study findings During the study period between May 22 and September 3, 2022, 14,504 mpox cases occurred across 29 jurisdictions in the USA. However, the researchers included only 6,605 mpox cases in the study analysis. Post-vaccination, the average time from vaccination to disease onset was 23 days. Specifically, 6,329 and 276 individuals, i.e., 95.8% and 4.2% of the study population, were unvaccinated and contracted mpox disease ≥14 days after receiving one dose of JYNNEOS, respectively.
The researchers had data on a minimum of one clinical symptom for 202/276 and 5,326/6,329 vaccinated and unvaccinated mpox cases, respectively. While vaccinated people most commonly reported rash, pruritis, and enlarged lymph nodes, unvaccinated people reported having rash, fever, and malaise. Conclusions To summarize, 276 mpox-infected cases in this study who had received one dose of the JYNNEOS vaccine greater than or 14 days before disease onset had similar but less frequent clinical symptoms than 6329 unvaccinated mpox patients. Although these clinical signs and symptoms were comparable to those identified early in the outbreak, vaccination with JYNNEOS substantially weakened the severity of mpox infections and the odds of systemic disease symptoms.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Duping antibodies with a decoy, researchers aim to prevent rejection of transplanted cellsResearchers at UCSF have developed a novel, potentially life-saving approach that may prevent antibodies from triggering immune rejection of engineered therapeutic and transplant cells.
Read more »
Edinburgh scientists work on restoring whisky flavoursResearchers will test 200-year-old barley varieties to see how they react to modern processing.
Read more »
COVID-19 vaccines, prior infection reduce transmission of omicron, finds study of California prisonsVaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first omicron wave, according to an analysis by researchers at UC San Francisco that examined transmission between people living in the same cell.
Read more »
George Mitchell scholarship: Concern over future fundingThere are concerns about the future of the George Mitchell scholarship which allows US college students to pursue a year of postgraduate study on the island of Ireland
Read more »
Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progressionPhase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression NEJM COVID19 coronavirus covid SARSCoV2
Read more »
Dry eye disease alters how the eye's cornea heals itself after injuryPeople with a condition known as dry eye disease are more likely than those with healthy eyes to suffer injuries to their corneas. Studying mice, researchers at Washington University School of Medicine in St. Louis have found that proteins made by stem cells that regenerate the cornea may be new targets for treating and preventing such injuries.
Read more »